Work

Mature results of MM‐011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma

Year: 2013

Type: article

Study design: Clinical Trial

Source: American Journal of Hematology

DOI: 10.1002/ajh.23639

Authors: Aleksandr Lazaryan, Mohamad A. Hussein, Frederic J. Reu, Beth Faiman, Becky Habecker, Mary Ann Karam, Janice Reed, Kimberly Hamilton, Joel Waksman, Kellie Bruening, Gordan Srkalovic, Steven Andresen, Matthew Kalaycio, John W. Sweetenham, Ronald Sobecks, Robert Dean, Robert Knight, Jerome B. Zeldis, Rachid Baz

Institutions: Cleveland Clinic, Celgene (United States), Sparrow Health System, Sparrow Hospital, University of California San Diego, University of South Florida, Moffitt Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1599228932

FWCI: 0.955

Cites: 23

Cited by: 10

Related to: 10